z-logo
open-access-imgOpen Access
Drug treatment of heart failure
Author(s) -
A. K. Brown
Publication year - 1993
Publication title -
morecambe bay medical journal
Language(s) - English
Resource type - Journals
eISSN - 2634-0631
pISSN - 1466-707X
DOI - 10.48037/mbmj.v1i10.1202
Subject(s) - digoxin , medicine , heart failure , digitalis , intensive care medicine , hydralazine , heart transplantation , scope (computer science) , digitoxin , drug , cardiology , transplantation , pharmacology , computer science , blood pressure , programming language
In my early years in Lancaster I remember my senior colleague Dr W J Hay asking whether or not digoxin and diuretics remained routine treatment for congestive cardiac failure; in fact there had been little change, in that digoxin was being used less often. Recently there have been three important alterations in management. These are:-( 1) improved diagnostic capabilities,(2) the introduction of new drugs, particularly ACE inhibitors, and(3) the reappraisal of older drugs including hydralazine, nitrates and digitalis. Finally we have seen the establishment of cardiac transplantation, various attempts at mechanical cardiac assistance and cardiomyoplasty which are out ide the scope of this article but which need to be borne in mind when drugs fail.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here